Skip to main content

Featured

Rising Tensions in the Gulf as Iran Threatens Oil Blockade

                                     An aerial view of the Iranian shores and Port of Bandar Abbas in the strait of Hormuz Iran has escalated regional tensions by declaring it will block all oil shipments from the Middle East if U.S. and Israeli attacks persist, prompting a stark warning from President Donald Trump of a far stronger American military response.  The Revolutionary Guards’ vow to halt “one litre of oil” from leaving the region has already rattled global markets, contributing to falling crude prices and surging equities as investors brace for potential disruption in the Strait of Hormuz—a vital chokepoint for global energy supplies. Trump responded by threatening unprecedented retaliation should Iran follow through, insisting the U.S. would strike “much harder” to ensure oil exports remain uninterrupted.  Despite the heated rhetoric, he expressed confid...

article

New Cystic Fibrosis Drug Offers Hope, but Comes with a High Price

A new drug for cystic fibrosis, Trikafta, is providing significant hope for patients suffering from the genetic disorder. Trikafta has been shown to reduce hospital visits and improve overall lung function, offering patients a better quality of life. For those living with cystic fibrosis, which affects the respiratory and digestive systems, this advancement is nothing short of a breakthrough.

However, the cost of Trikafta is a major concern. Priced at around $300,000 per year, the drug is prohibitively expensive for many patients and their families. While some health programs and insurance plans may cover the cost, access to this life-changing medication remains a challenge.

As the debate over drug pricing and healthcare accessibility continues, the medical community and patient advocacy groups are calling for measures to ensure that Trikafta is available to all who need it, regardless of their financial situation.


Comments